Impact of the international reference pricing on access to standard therapy drugs for asthma and COPD
BackBibliographic information
- Publication year
- 2016
- Category
- AFG — Abstracts of papers from foreign scientific conferences
- CREPČ / EPCA ID
- 0026092
- Document type
- Article in proceedings
- Source
- Value In Health
- ISSN (Source)
- 1098-3015
- Volume
- Vol. 19, č. 7(2016), s. A560
- Source publication year
- 2016
- Language
- English
- Research areas
- 180 — Medical, pharmaceutical and non-medical health sciences
- Links
Bibliographic record
VIŠŇANSKÝ, Martin - KABABIKOVÁ, Diana. Impact of the international reference pricing on access to standard therapy drugs for asthma and COPD [Dopad medzinárodného referencovania cien na dostupnosť štandardnej terapie astmy a CHOCHP]. In: ISPOR : Congress. Value In Health. 2016. ISSN 1098-3015, Vol. 19, č. 7(2016), s. A560. (2016: 3.824 - IF, 97 - H-index, 4.491 - IF 5y, 1.908 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 1.63 - ABDC).
Publication authors
| Author | Role | Share |
|---|---|---|
| Martin Višňanský | Author | 70.000 % |
| Diana Kababiková | Author | 30.000 % |
Metrics
IF 3.824IF5 4.491SJR Q 1JCR Q 1SJR 1.908H-index 97ABDC 1.63Metrics year 2016